Handgun, Individual, Community Factors Predict Suicide by Firearm

MONDAY, July 11, 2022 (HealthDay News) -- Among handgun purchase transactions classified in the riskiest 5 percent, more than one-third are associated with a purchaser who died by firearm suicide within one year, according to a study published online July 11 in JAMA Network Open.
Hannah S. Laqueur, Ph.D., from University of California, Davis, in Sacramento, and colleagues assessed whether a statewide database of handgun transaction records, coupled with machine learning techniques, can forecast firearm suicide risk. The analysis included nearly 4.98 million handgun transactions (1.95 million individuals) from the California Dealer's Records of Sale database (1996 to 2015), with suicides determined from California death records (1996 to 2016).
The researchers found that firearm suicide within one year occurred in 0.07 percent of handgun transactions (3,278 transactions among 2,614 individuals). More than one-third of observed firearm suicides (38.6 percent) were among transactions classified in the highest-risk ventile, with 95 percent specificity. More than two-thirds (24 of 35) of transactions with a random forest score greater than 0.95 were associated with a purchaser who died by firearm suicide within one year. Known risk factors, such as older age at first purchase, and previously unreported predictors, including distance to firearms dealer and month of purchase, were important predictive features.
"This study suggests that passively collected administrative data on handgun transactions may be used to inform targeted interventions based on risk stratification," the authors write.
Related Posts
Gene Tests Often Reveal Unknown Relatives
MONDAY, Feb. 28, 2022 (HealthDay News) -- Who hasn't had the urge to trace...
Healthy Plant-Based Diet May Cut Breast Cancer Risk
TUESDAY, June 14, 2022 (HealthDay News) -- Adherence to a healthful plant-based...
1990 to 2019 Saw Improvement in Women’s Representation in Academic Medicine
WEDNESDAY, Dec. 28, 2022 (HealthDay News) -- Representation of women in academic...
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
MONDAY, Dec. 5, 2022 (HealthDay News) -- The last of six COVID-19 monoclonal...